Noah Medical

Noah Medical (operating at noahmed.com) is a pioneering medical robotics company specializing in next-generation robotic platforms for precision diagnosis and treatment of endoluminal conditions. Founded in 2018 by Jian Zhang, PhD, and headquartered in San Jose, California, Noah Medical addresses critical gaps in early-stage cancer detection and minimally invasive procedures. Its flagship technology combines real-time localization, robotic targeting, and automated confirmation to achieve a diagnostic yield of 96.7%—far exceeding traditional methods. By integrating AI-driven robotic arms with advanced imaging, the platform enables clinicians to perform faster, more accurate procedures with reduced radiation exposure and fewer complications. This empowers hospitals and diagnostic centers to deliver faster case turnaround while maintaining strict adherence to ATS standards. Backed by a $150 million Series B funding round in April 2023, Noah Medical has attracted institutional investors including UpHonest Capital and Primavera Venture, fueling its mission to revolutionize endoluminal solutions in precision medicine.